ArticleClinical and experimental pharmacology & physiology2022

Dihydroartemisinin protects blood-brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1.

Fuhong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.